CRISPR Screen Dataset
Uijttewaal ECH (2024) - 3-PMID39681701
Title: CRISPR-StAR enables high-resolution genetic screening in complex in vivo models.
Screen Details:
- Screen Rationale : Increased/decreased drug resistance
- Cell Type : Melanoma Cell Line [BTO:0000849]
- Cell Line : YUMM1.7 [CELLOSAURUS:CVCL_JK16]
- Phenotype : Response To Chemicals
- Condition : dabrafenib (100.0 nM) [PubChem]
- Library : Targeted CRISPRn library in CRISPR-StAR vector (Elling, 2024) | Type: CRISPRn | Format: Pool | Enzyme: Cas9 | Methodology: Knockout
- Analysis Method : CRISPR-StAR–MAGeCK analysis pipeline | Number of Hits: 29 | Full Dataset Size: 538
- Experimental Setup : Drug Exposure | Duration: 14 Days | MOI: = 0.25
- Significance : Authors have indicated that results with Score.1 (Log2FC) < -1.5 OR Score.1 (Log2FC) > 1.0 are to be considered significant. These results are indicated by '' in the HIT column of the table below.
Notes:
- Hit genes show increased (negative log2fc) or decreased (positive log2fc) sensitivity to dabrafenib upon KO
Score Distribution
< 1.7975
> -5.8381